HDAC6 and Miyoshi myopathy: With respect to PD-L1 expression in MM cells, panobinostat, entinostat (class I HDAC-specific inhibitor) and ricolinostat (HDAC6 inhibitor) upregulated PD-L1 in these cells probably by histone acetylation of the PDL1 gene promoter [163].